Jonathan Esensten, MD, PhD
|University of California, San Francisco||M.D.|| Medicine||2012|
|University of California, San Francisco||Ph.D.|| Graduate Division (Biomedical Sciences)||2010|
|University of California, San Francisco||Residency, Clinical Pathology||Laboratory Medicine||2016|
|University of California, San Francisco||Fellowship, Transfusion Medicine and Blood Banking||Laboratory Medicine||2015|
|University of California, San Francisco||2016
||2019||Leukemia and Lymphoma Society Fellow|
|San Francisco General Hospital||2013
||2013||Krevans Award in Laboratory Medicine|
|University of California, San Francisco||2010
||2010||Alpha Omega Alpha Honor Society|
Dr. Jonathan Esensten is a Leukemia and Lymphoma Society Fellow in the laboratory of Dr. Wendell Lim. His research is focused the development of synthetic and chemical biology approaches for T cell therapeutics. He is Medical Director of the UCSF HICTF and GMP Facility, which manufactures regulatory T cell products for clinical trials, among other cell therapy activities. He completed residency in clinical pathology and fellowship in transfusion medicine and blood banking at UCSF.
synthetic biology, cellular therapy, chimeric antigen receptor T cells, immunology, T cell therapeutics
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.